Are These 2 Big Pharmas Really Buyout Candidates?
AstraZeneca and Bristol-Myers Squibb's names have both repeatedly surfaced on the buyout rumor mill this year. Do these rumors have legs, or are they nothing more than speculation?
3 Big Biotech Buybacks That Investors Should Love
Big biotech companies are flush with cash and are using it to reward shareholders. Here are three companies that are spending big on share buybacks.
Stocks: 5 things to know before the open
Premarkets: 5 things to know before the open
3 Stocks for Retirees to Buy
Retirees should be looking for rock-solid businesses that offer good long-term growth prospects and shareholder friendly management teams. Here are 3 company's that fit the bill today.